Bookmark
Forward
Explore Literature Results
QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=53E003F0E0D66E7217F92F0CBE490D0E;jsessionid=32E1CD61891AE524FE4262F6B74FB369;jsessionid=22279C76FD9912FD26129DC92407D03D;jsessionid=D1BA509C57CB66E81BC4870E17FA998D;jsessionid=5B325E1B8C2F27D4D25E7028D257C15E (gene)
Most Relevant Literature
- Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
- Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
- Stability of varicella-zoster virus open reading frame 63.
- Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
- Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Most Relevant Clinical Trials
There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=53E003F0E0D66E7217F92F0CBE490D0E;jsessionid=32E1CD61891AE524FE4262F6B74FB369;jsessionid=22279C76FD9912FD26129DC92407D03D;jsessionid=D1BA509C57CB66E81BC4870E17FA998D;jsessionid=5B325E1B8C2F27D4D25E7028D257C15E
Explore Clinical Trials Results
